See Tai Sandi 4
4 · Lexeo Therapeutics, Inc. · Filed Aug 20, 2025
Insider Transaction Report
Form 4
See Tai Sandi
Chief Development Officer
Transactions
- Sale
Common Stock
2025-08-18$4.67/sh−382$1,783→ 58,860 total
Footnotes (2)
- [F1]Represents a sale to cover tax obligations on the release of restricted stock units ("RSUs").
- [F2]Includes 49,138 RSUs.